Search

everythinglearnresearchcommunity

for

Search:↓

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Dupilumab for eczema may cause hair loss.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Somatostatin may help protect hair follicles from immune attacks.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Apremilast did not work for treating severe alopecia areata.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

New psoriasis treatments are effective but come with side effects and risks.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.